Advances in Alzheimer’s disease: mechanistic insights and therapeutic targets

Key Points

• Alzheimer's disease therapies may improve cognitive functions and slow progression.
• Significant biomarkers include amyloid and tau proteins, indicating disease severity.
• A mechanistic approach focuses on neural pathways involved in memory and cognition.
• Understanding pathophysiology can enable the development of targeted treatments.